TDMS Study 89029-13 Pathology Tables
NTP Experiment-Test: 89029-13 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03
Study Type: SUBCHRON 90-DAY MAGNETIC FIELDS + DMBA INITIATION PROMOTION Date: 12/20/97
Route: MAGNETIC FIELDS Time: 14:41:18
8MG(2MGX4)DMBA VS 50 HZ/1G 8MG(2MGX4)DMBA VS 50 HZ/5G 8MG(2MGX4)DMBA
Facility: Battelle Northwest
Chemical CAS #: EMF + DMBA
Lock Date: 10/24/97
Cage Range: All
Reasons For Removal: All
Removal Date Range: All
Treatment Groups: Include All
a Number of animals examined microscopically at site and number of animals with lesion
Page 1
NTP Experiment-Test: 89029-13 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03
Study Type: SUBCHRON 90-DAY MAGNETIC FIELDS + DMBA INITIATION PROMOTION Date: 12/20/97
Route: MAGNETIC FIELDS Time: 14:41:18
____________________________________________________________________________________________________________________________________
SPRAGUE-DAWLEY RATS FEMALE 8 DMBA 50 HZ/1G 50 HZ/5G
CONTROL 8 DMBA 8 DMBA
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially In Study 100 100 100
Early Deaths
Moribund Sacrifice 1
Survivors
Terminal Sacrifice 100 100 99
Animals Examined Microscopically 100 100 100
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
None
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
None
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
None
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
Mammary Gland (100) (100) (100)
Galactocele 1 (1%)
a Number of animals examined microscopically at site and number of animals with lesion
Page 2
NTP Experiment-Test: 89029-13 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03
Study Type: SUBCHRON 90-DAY MAGNETIC FIELDS + DMBA INITIATION PROMOTION Date: 12/20/97
Route: MAGNETIC FIELDS Time: 14:41:18
____________________________________________________________________________________________________________________________________
SPRAGUE-DAWLEY RATS FEMALE 8 DMBA 50 HZ/1G 50 HZ/5G
CONTROL 8 DMBA 8 DMBA
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM - CONT
Hyperplasia 1 (1%)
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
None
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
None
a Number of animals examined microscopically at site and number of animals with lesion
Page 3
------------------------------------------------------------
---------- END OF REPORT ----------
------------------------------------------------------------